Who Is a Suitable Candidate for DBS Surgery?
In brief: A suitable candidate for deep brain stimulation usually has a diagnosis of idiopathic Parkinson’s disease, motor symptoms that respond to levodopa and troublesome fluctuations, dyskinesia or tremor that are no longer adequately controlled throughout the day. Cognitive health, psychiatric stability, general medical fitness and realistic expectations are also essential.
DBS can be highly valuable for appropriately selected patients, but it is not suitable for every person with Parkinson’s disease. Patient selection is one of the most important factors influencing the outcome of treatment.
The decision should not be based on age, disease duration or MRI findings alone. It requires a detailed assessment of the patient’s diagnosis, symptoms, medication response, cognition, general health and personal treatment goals.
Is the diagnosis definitely Parkinson’s disease?
The first step is to confirm that the patient’s condition is consistent with idiopathic Parkinson’s disease.
Other neurological conditions—including multiple system atrophy, progressive supranuclear palsy, dementia with Lewy bodies and corticobasal syndrome—may initially resemble Parkinson’s disease but generally respond less predictably to standard Parkinson’s DBS.
Features such as very early falls, rapidly progressive balance problems, severe autonomic dysfunction, early cognitive decline or a poor response to levodopa may suggest an atypical parkinsonian disorder. These findings do not establish a diagnosis by themselves, but they require careful neurological evaluation before surgery is considered.
Which symptoms make DBS worth considering?
DBS may be considered when one or more of the following problems interfere with quality of life despite appropriately adjusted medication:
Medication benefit wears off before the next dose
“Off” periods become prolonged or unpredictable
Dyskinesia limits daily activities
Tremor remains disabling despite medication
Motor symptoms fluctuate considerably throughout the day
Medication side effects prevent further dose adjustment
Symptoms interfere with work, independence or essential daily activities
Patients do not need to wait until every aspect of the disease has become severe. A recent international expert consensus recommends timely referral when troublesome motor symptoms affect quality of life despite optimized treatment.
An assessment can be performed while the neurologist continues to adjust medication. Referral for DBS evaluation does not mean that surgery has already been decided.
Why is the response to levodopa important?
The response to levodopa helps predict which motor symptoms are likely to improve with DBS.
In general, symptoms that improve during a patient’s best medication “on” state—such as rigidity, slowness and some gait difficulties—are more likely to respond to stimulation.
Tremor can be an important exception. Some patients with medication-resistant tremor may still respond well to DBS.
A formal levodopa challenge test may be performed during the evaluation. The patient is examined in an “off medication” state and again after receiving levodopa. This helps the team identify which symptoms are dopamine-responsive and establish realistic treatment goals.
Which symptoms respond less predictably?
DBS does not improve every symptom of Parkinson’s disease. The response may be limited or unpredictable for:
Balance problems that do not improve with levodopa
Levodopa-resistant freezing of gait
Speech impairment
Swallowing difficulty
Significant cognitive impairment
Autonomic symptoms such as blood pressure or bladder dysfunction
If these are the patient’s main disabling problems, the expected benefit of DBS may be limited.
When I discuss DBS with patients, I focus on one central question: Are the symptoms that most affect this patient’s life symptoms that DBS is realistically likely to improve?
You can read an overview of the treatment in Deep Brain Stimulation for Parkinson’s Disease: A Patient’s Guide.
Is there an age limit for DBS?
There is no single age cut-off that applies to every patient.
Increasing age may be associated with greater surgical risk, frailty, cognitive concerns and a more complex recovery. However, a healthy older patient with disabling levodopa-responsive symptoms may still be considered, while a younger patient with an uncertain diagnosis or significant cognitive impairment may not be suitable.
The assessment should consider biological health, frailty, cognition, disease pattern and the balance between expected benefit and risk rather than age alone.
How do cognition and mental health affect candidacy?
Neuropsychological assessment is an important part of DBS evaluation. Significant dementia is generally a contraindication because surgery and stimulation may worsen confusion or reduce the patient’s ability to manage the device and follow-up process.
Depression, anxiety, impulsivity, hallucinations and other psychiatric symptoms should also be assessed. A previous psychiatric diagnosis does not automatically exclude DBS, but unstable or untreated symptoms should usually be managed before surgery.
Family involvement can be particularly valuable when cognitive, emotional or behavioural concerns are present.
Does general health matter?
DBS is an elective intracranial procedure. The patient must be medically fit for surgery and anaesthesia.
The team may evaluate:
Heart and lung health
Blood pressure and diabetes control
Use of anticoagulant or antiplatelet medication
Previous infections
Brain MRI findings
Skin and wound-healing risks
The patient’s ability to attend programming and follow-up appointments
Medical conditions do not always prevent surgery, but they can change the risk–benefit assessment or require treatment before proceeding.
Why are expectations important?
DBS does not cure Parkinson’s disease and does not stop its progression. It is unlikely to improve every motor and non-motor symptom.
Realistic goals may include:
Reducing “off” time
Controlling troublesome dyskinesia
Improving tremor
Making movement more predictable
Increasing independence in daily activities
Improving quality of life
The goal is not necessarily to stop all medication. Many patients continue to require Parkinson’s medication after surgery, although the dose may sometimes be reduced.
A patient should also understand that DBS requires ongoing programming, medication adjustment and neurological follow-up.
What assessments are performed before surgery?
A comprehensive evaluation may include:
Assessment by a movement-disorders neurologist
Consultation with a functional neurosurgeon
Review of medication history and motor fluctuations
Levodopa challenge testing
Brain MRI
Neuropsychological testing
Psychiatric evaluation when indicated
Medical and anaesthetic assessment
Discussion of the patient’s goals and family support
The final recommendation is ideally made through a multidisciplinary process.
Who may not be an ideal candidate?
DBS may be unsuitable or require additional caution when there is:
An uncertain diagnosis or suspected atypical parkinsonism
Significant dementia
Uncontrolled psychiatric illness
Motor symptoms that show little levodopa response, apart from selected tremor cases
Severe levodopa-resistant balance or gait impairment as the main problem
Medical conditions that create unacceptable surgical risk
Active infection
Expectations that DBS will cure the disease or correct every symptom
Inability to attend programming and long-term follow-up
Some of these factors are temporary or treatable. For this reason, evaluation may result in surgery, continued medical optimization, reassessment at a later stage or consideration of another device-assisted therapy.
Can international patients have a preliminary assessment?
International patients may be able to undergo an initial remote review before travelling. Useful records can include:
Neurology reports
Current and previous medication schedules
Videos showing “on” and “off” periods
Brain MRI files
Neuropsychological reports, if available
A description of the symptoms that most affect daily life
A remote review can help determine whether a complete DBS evaluation is reasonable. Final candidacy usually requires an in-person neurological, neuropsychological and surgical assessment.
Frequently asked questions
Do I need to have Parkinson’s disease for a certain number of years?
Disease duration is considered, but it should not be used in isolation. Diagnostic certainty, symptom pattern, medication response and quality-of-life impact are more important than reaching a specific year.
Does severe tremor make someone a candidate?
Disabling tremor that remains uncontrolled despite appropriate medication can be an indication for DBS, including in some patients whose tremor responds poorly to levodopa.
Can a person with mild memory problems undergo DBS?
Mild cognitive changes do not automatically exclude surgery, but detailed neuropsychological testing is required. Significant dementia generally makes DBS unsuitable.
Is being referred for DBS the same as deciding to have surgery?
No. Referral means that the patient’s suitability should be assessed. Surgery is recommended only when the expected benefits justify the risks and treatment burden.
Conclusion
The best DBS candidates are not defined by age or disease duration alone. They usually have a well-established diagnosis of Parkinson’s disease, levodopa-responsive motor symptoms and disabling fluctuations, dyskinesia or tremor despite optimized medical treatment.
Cognitive status, psychiatric health, surgical fitness, expectations and access to long-term follow-up must also be considered. A multidisciplinary evaluation is therefore essential before proceeding.
Dr. Kaan Tugberk OzdemirNeurosurgeon – Izmir, Türkiye
This article is intended for general educational purposes and does not replace an individual neurological or neurosurgical assessment.
References
Comments